Tweet
CDISC and DCRI Announce International Tuberculosis Data Standards Meeting
CDISC and DCRI Announce International Tuberculosis Data Standards Meeting
Oct 31 2006, 11:04 AM EST
BIOWIRE
The Clinical Data Interchange Standards Consortium (CDISC) in partnership with Duke Clinical Research Institute (DCRI) is pleased to announce an informational session and luncheon focused on Tuberculosis (TB) Data Standards. This open event will be held on Saturday, November 4, 2006 in conjunction with the 37th Union World Conference on Lung Health in Paris, France.
This meeting is part of an over-arching initiative to create international TB Data Standards and is sponsored under a US National Institutes of Health (NIH) contract. The meeting is intended to inform and engage the broader TB Community with regard to current and future development of global TB Data Standards. A key component of this initiative, the "TB Roadmap" project, is to improve the exchange and interoperability of information critical for TB research. Therapeutic data standards for TB will facilitate the integration and aggregation of data across both the TB research and the healthcare spectrums.
DCRI has also partnered with CDISC on an additional NIH contract to develop Cardiology data standards under a sister project known as the CV (Cardiovascular) Roadmap. Robert Califf, M.D., Vice Chancellor for Clinical Research at the Duke University Medical Center, said, "The two NIH Roadmap projects housed at the DCRI have been extremely well-served by our close collaboration with CDISC in developing data standards that are important to the clinical research community. Stakeholders from two different clinical research communities, Tuberculosis and Cardiovascular diseases, have profited from our CDISC partnership." Dr. David Hardison, Chair of the CDISC Board of Directors, says of this work, "CDISC is grateful to both the NIH and DCRI for the opportunity to collaborate on these disease-specific standards to improve medical research and related areas of health care."
To build consensus around this important work, an international TB Working Group (TBWG) was kicked-off in May, comprised of key TB stakeholders including: Centers for Disease Control & Prevention (CDC), Global Alliance for TB Drug Development, National Heart Lung & Blood Institute (NHLBI), Foundation for Innovative New Diagnostics (FIND), global pharmaceutical companies and many other leaders and experts from the international TB community.
Considering TB data from over 10 global research and surveillance databases, the TBWG is currently developing a standard subset of TB-specific terms and definitions for Diagnosis and Treatment. This initial work product is known as TB Package-1. Future work will focus on standards for Latent TB and Multi-Drug Resistant TB. Once in production, these "open source" standards will provide international TB researchers and experts a means to: (1) aggregate and compare TB data from various databases; (2) develop protocols and standard data collection forms more effectively; and (3) identify patients more quickly for enrollment.
Dr. Richard O'Brien, Head of Product Evaluation for FIND Diagnostics, stated, "The environ-ment is ready for an international set of TB Data Standards. In the fight against TB, the ability to easily aggregate data across research, and share healthcare and surveillance data is a global priority as new strains of TB become ever more resistant to existing treatment with leading biopharmaceutical compounds. Data standards with common terminology for TB are the key to the necessary pooling and analysis of larger data sets."
In order to ensure broad acceptance of TB Data Standards around the world, CDISC and DCRI wish to expand international participation for the TBWG. For more information, we encourage you to join us for a luncheon meeting in Paris from 12:30-3:00 pm on Saturday, November 4, 2006. Please contact Bron Kisler, CDISC Terminology Program Director, at bkisler@cdisc.org for additional details. For additional information about the TB Data Standards initiative you may also contact Anita Walden at anita.walden@duke.edu.
About CDISC
CDISC is a global, open, multidisciplinary, non-profit organization that has developed standards to support the acquisition, exchange, submission and archive of clinical trial data and metadata. The CDISC mission is to develop and support global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of healthcare. CDISC standards are vendor-neutral, platform-independent and freely available via the CDISC website.
CDISC is made possible through the generous support of its members, sponsors, and volunteer participants. These include academia, biopharmaceutical companies, technology and service providers, institutional review boards and anyone interested in streamlining biopharmaceutical product development and improving clinical data quality and healthcare. CDISC also has joint memberships with HL7, HIMSS, AMIA and CPATH Institute.
http://www.genengnews.com/news/bnitem.aspx?name=7880831
Oct 31 2006, 11:04 AM EST
BIOWIRE
The Clinical Data Interchange Standards Consortium (CDISC) in partnership with Duke Clinical Research Institute (DCRI) is pleased to announce an informational session and luncheon focused on Tuberculosis (TB) Data Standards. This open event will be held on Saturday, November 4, 2006 in conjunction with the 37th Union World Conference on Lung Health in Paris, France.
This meeting is part of an over-arching initiative to create international TB Data Standards and is sponsored under a US National Institutes of Health (NIH) contract. The meeting is intended to inform and engage the broader TB Community with regard to current and future development of global TB Data Standards. A key component of this initiative, the "TB Roadmap" project, is to improve the exchange and interoperability of information critical for TB research. Therapeutic data standards for TB will facilitate the integration and aggregation of data across both the TB research and the healthcare spectrums.
DCRI has also partnered with CDISC on an additional NIH contract to develop Cardiology data standards under a sister project known as the CV (Cardiovascular) Roadmap. Robert Califf, M.D., Vice Chancellor for Clinical Research at the Duke University Medical Center, said, "The two NIH Roadmap projects housed at the DCRI have been extremely well-served by our close collaboration with CDISC in developing data standards that are important to the clinical research community. Stakeholders from two different clinical research communities, Tuberculosis and Cardiovascular diseases, have profited from our CDISC partnership." Dr. David Hardison, Chair of the CDISC Board of Directors, says of this work, "CDISC is grateful to both the NIH and DCRI for the opportunity to collaborate on these disease-specific standards to improve medical research and related areas of health care."
To build consensus around this important work, an international TB Working Group (TBWG) was kicked-off in May, comprised of key TB stakeholders including: Centers for Disease Control & Prevention (CDC), Global Alliance for TB Drug Development, National Heart Lung & Blood Institute (NHLBI), Foundation for Innovative New Diagnostics (FIND), global pharmaceutical companies and many other leaders and experts from the international TB community.
Considering TB data from over 10 global research and surveillance databases, the TBWG is currently developing a standard subset of TB-specific terms and definitions for Diagnosis and Treatment. This initial work product is known as TB Package-1. Future work will focus on standards for Latent TB and Multi-Drug Resistant TB. Once in production, these "open source" standards will provide international TB researchers and experts a means to: (1) aggregate and compare TB data from various databases; (2) develop protocols and standard data collection forms more effectively; and (3) identify patients more quickly for enrollment.
Dr. Richard O'Brien, Head of Product Evaluation for FIND Diagnostics, stated, "The environ-ment is ready for an international set of TB Data Standards. In the fight against TB, the ability to easily aggregate data across research, and share healthcare and surveillance data is a global priority as new strains of TB become ever more resistant to existing treatment with leading biopharmaceutical compounds. Data standards with common terminology for TB are the key to the necessary pooling and analysis of larger data sets."
In order to ensure broad acceptance of TB Data Standards around the world, CDISC and DCRI wish to expand international participation for the TBWG. For more information, we encourage you to join us for a luncheon meeting in Paris from 12:30-3:00 pm on Saturday, November 4, 2006. Please contact Bron Kisler, CDISC Terminology Program Director, at bkisler@cdisc.org for additional details. For additional information about the TB Data Standards initiative you may also contact Anita Walden at anita.walden@duke.edu.
About CDISC
CDISC is a global, open, multidisciplinary, non-profit organization that has developed standards to support the acquisition, exchange, submission and archive of clinical trial data and metadata. The CDISC mission is to develop and support global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of healthcare. CDISC standards are vendor-neutral, platform-independent and freely available via the CDISC website.
CDISC is made possible through the generous support of its members, sponsors, and volunteer participants. These include academia, biopharmaceutical companies, technology and service providers, institutional review boards and anyone interested in streamlining biopharmaceutical product development and improving clinical data quality and healthcare. CDISC also has joint memberships with HL7, HIMSS, AMIA and CPATH Institute.
http://www.genengnews.com/news/bnitem.aspx?name=7880831